SER
Serina Therapeutics Inc
2.20$
-5.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10,544.8% | -99.8% | +920.0% | -72.5% | -200.0% | – | – | -100.0% | – | – | – | – | |
| – | -88.7% | +316.7% | +128.0% | +4,136.8% | -2.1% | -99.3% | -5.9% | +22,718.8% | -6.8% | -99.5% | – | – | |
| – | – | -100.6% | – | – | – | – | – | -3,302.6% | – | – | – | – | |
| – | +64.9% | +21.9% | +44.1% | +51.5% | -2.1% | +24.8% | +6.8% | +15.8% | -6.8% | -5.9% | +19.3% | – | |
| – | +118.1% | -37.1% | +90.4% | +25.3% | -49.6% | +98.2% | -12.5% | +7.8% | -5.0% | +18.4% | -3.7% | – | |
| – | +97.4% | -19.0% | +68.0% | -24.7% | +8.9% | +84.8% | -3.1% | -51.7% | +2.4% | +123.2% | +8.3% | – | |
| – | – | -1,063.1% | – | – | – | – | – | – | – | – | – | – | |
| – | +76.0% | -43.8% | +144.4% | -93.4% | +6.3% | -100.0% | – | -33.3% | +3,200.0% | -4.5% | +7.4% | – | |
| – | -40.0% | -1,528.6% | – | -73.3% | -299.0% | – | – | – | – | – | – | – | |
| – | -116.7% | – | -127.3% | – | – | – | – | – | – | -61.1% | – | – | |
| – | -40.0% | -1,528.6% | – | -72.9% | -294.3% | – | – | – | – | – | – | – | |
| – | -35.3% | -1,300.6% | – | -73.4% | -284.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.